Los puntos clave no están disponibles para este artículo en este momento.
The survival prediction model can be used to make individualized predictions of the expected survival benefit from the addition of adjuvant chemotherapy for patients with stage II or stage III gastric cancer.
Jiang et al. (Wed,) studied this question.